Randomized clinical trials towards a single‐visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG‐101 in chronic hepatitis C patients and long‐acting injectable GSK2878175 in healthy participantsYanli Deng, Martin Leivers, Fiona Campbell et al.|Journal of Viral Hepatitis|2020Cited by 32
Real-world clinical practice outcomes in hepatitis C-infected patients with psychiatric and substance use disorders treated with glecaprevir/pibrentasvir for 8 or 12 weeks: a pooled analysis across nine countriesPietro Lampertico, Georges‐Philippe Pageaux, Ioannis Goulis et al.|Journal of Hepatology|2020Cited by 2